Page last updated: 2024-08-05 11:19:01
sesquiterpene
A C15 terpene.
ChEBI ID: 35189
Members (17)
Member | Definition | Role |
---|---|---|
alpha-bergamotene | A sesquiterpene consisting of a bicyclo[3.1.1]hept-2-ene skeleton substituted at positions 2 and 6 by methyl groups and at position 6 by a 4-methylpent-3-en-1-yl group. | alpha-bergamotene |
alpha-curcumene | A sesquiterpene that is 2-methyl-2-heptene in which one of the hydrogens at position 6 is substituted by a p-tolyl group. | alpha-curcumene |
amorpha-4,11-diene | amorpha-4,11-diene | |
cadinane | A sesquiterpene consisting of decalin having two methyl substituents at the 1- and 6-positions, an isopropyl substituent at the 4-position and (1S,4S,4aS,6S,8aS)-configuration. | cadinane |
cedrene | A sesquiterpene that is cedrane which has a double bond between positions 8 and 9. | cedr-8-ene |
drimane | drimane | |
epi-isozizaene | (+)-epi-isozizaene | |
eudesmane | eudesmane | |
germacrene a | germacrene A | |
guaiane | guaiane | |
guaiazulene | guaiazulene | |
guaiene | beta-Guaiene | |
pentalenene | pentalenene | |
sativene | A sesquiterpene that is octahydro-1H-1,4-methanoindene bearing methyl, isopropyl and methylene substituents at positions 4, 7 and 8 respectively (the 1R,3aS,4R,7R,7aR-isomer). | sativene |
trichodiene | trichodiene | |
valencene | A carbobicyclic compound and sesquiterpene that is 1,2,3,4,4a,5,6,7-octahydronaphthalene which is substituted a prop-1-en-2-yl group at position 3 and by methyl groups at positions 4a and 5 (the 3R,4aS,5R- diastereoisomer). | (+)-valencene |
zingiberene | 2-Methylcyclohexa-1,3-diene in which a hydrogen at the 5 position is substituted (R configuration) by a 6-methyl-hept-5-en-2-yl group (S configuration). It is a sesquiterpene found in the dried rhizomes of Indonesian ginger, Zingiber officinale. | zingiberene |
Research
Studies (698)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 32 (4.58) | 18.7374 |
1990's | 14 (2.01) | 18.2507 |
2000's | 149 (21.35) | 29.6817 |
2010's | 356 (51.00) | 24.3611 |
2020's | 147 (21.06) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 4 (0.54%) | 5.53% |
Reviews | 23 (3.12%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 710 (96.34%) | 84.16% |